HCID 68284104, compound → HCID 68283812, compound

HRID 2408734Notes

Reaction equation

HRID 2408734 reaction equation
[CH3:1][O:2][C:3](=[O:28])[CH2:4][C:5]([C:22]1[CH:27]=[CH:26][N:25]=[CH:24][CH:23]=1)=[CH:6][N:7]1[C:15]2[CH:14]=[CH:13][C:12]([CH3:16])=[CH:11][C:10]=2[C:9]2[CH2:17][N:18]([CH3:21])[CH2:19][CH2:20][C:8]1=2>CO.[Pd]>[CH3:1][O:2][C:3](=[O:28])[CH2:4][CH:5]([C:22]1[CH:23]=[CH:24][N:25]=[CH:26][CH:27]=1)[CH2:6][N:7]1[C:15]2[CH:14]=[CH:13][C:12]([CH3:16])=[CH:11][C:10]=2[C:9]2[CH2:17][N:18]([CH3:21])[CH2:19][CH2:20][C:8]1=2

Participants

4

Procedure

4-(2,8-Dimethyl-1,2,3,4-tetrahydro-pyrido[4,3-b]indol-5-yl)-3-pyridin-4-yl-but-3-enoicacid methyl ester (100 mg, 0.266 mmol) was dissolved in MeOH (10 mL) and 10% dry Pd/C (50 mg) was added and hydrogen gas was purged in to the reaction mixture at RT for 12 h. The reaction was monitored by TLC and LCMS. After consumption of starting material, the reaction mixture was filtered through Celite. The filtrate was concentrated to obtain the crude product, which was recrystallized in ether-hexane to obtained 50 mg of 4-(2,8-dimethyl-1,2,3,4-tetrahydro-pyrido[4,3-b]indol-5-yl)-3-pyridin-4-yl-butyric acid methyl ester. 1H NMR (CDCl3, freebase) δ (ppm): 8.47 (d, 2H), 7.18 (s, 1H), 7.16 (d, 1H), 6.98 (d, 3H), 4.22 (dd, 1H), 4.05 (dd, 1H), 3.7 (m, 2H), 3.57 (s, 3H), 3.5 (dd, 1H), 2.74 (m, 3H), 2.71 (m, 2H), 2.49 (s, 3H), 2.43 (s, 3H), 2.2 (m, 1H). Separation by chiral HPLC provides enantiomers II-223a-b.

Workup

  1. customhydrogen gas was purged in to the reaction mixture at RT for 12 h
  2. customAfter consumption of starting material
  3. filtrationthe reaction mixture was filtered through Celite
  4. concentrationThe filtrate was concentrated
  5. customto obtain the crude product, which
  6. customwas recrystallized in ether-hexane

Sources & evidence

ORD record
ord-aef0a9b0ce2e4b35923d4aeecccd2896
Source dataset
uspto-grants-2014_08
Patent number
US08815843B2

Reaction notes

Loading…